Market Overview

UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Monsanto Company

Share:
Related MON
Monsanto Q3 Earnings Beat Estimates
Keep an Eye on These 7 Stocks for June 24, 2015
Monsanto: Neutral On Overvaluation And Lowered Q4 Outlook (Seeking Alpha)

In a report published Wednesday, Canaccord Genuity reiterated its Buy rating on Monsanto Company (NYSE: MON), and raised its price target from $104.00 to $113.00.

Canaccord Genuity noted, “From an industry viewpoint, we continue to expect another record planting in the US this spring, followed by a further record planting in Latin America next fall, which should set up the company for a strong F2013 and a positive start to F2014. We believe Monsanto will be able to capitalize on these expected macro events more than its peers due to its yield leading products, both current and those in the pipeline, and the benefit that we should continue to see roll out in both North and South America throughout our forecast period. From a pipeline viewpoint, we see no equal when it relates to the level of product launches the company should be able to introduce both in the near and medium term. As a result, we believe the company's shares will continue to outperform its peers and the market in 2013.”

Monsanto Company closed on Tuesday at $98.45.

Latest Ratings for MON

DateFirmActionFromTo
Jun 2015BarclaysMaintainsEqual-weight
Jun 2015Atlantic EquitiesUpgradesUnderweightNeutral
May 2015Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Analyst Ratings

 

Related Articles (MON)

Around the Web, We're Loving...

Get Benzinga's Newsletters